newsfilter
← Latest News
PR Newswire·

Theseus Pharmaceuticals Appoints Don Hayden to Board of Directors

CAMBRIDGE, Mass., May 18, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and comme